Leap Therapeutics, Inc. (LPTX)

NASDAQ: LPTX · IEX Real-Time Price · USD

1.690

-0.180 (-9.63%)

At close: Jul 2, 2024, 4:00 PM

1.720

+0.030 (1.78%)

After-hours: Jul 2, 2024, 6:30 PM EDT

Leap Therapeutics Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018 - 2013
Net Income	-81.41	-54.6	-40.59	-37.59	-33.26	Upgrade
Depreciation & Amortization	0.02	0.02	0.03	0.03	0.05	Upgrade
Share-Based Compensation	5.13	5.18	3.69	2.57	3.73	Upgrade
Other Operating Activities	32.52	0.36	1.72	-1.05	2.22	Upgrade
Operating Cash Flow	-43.75	-49.04	-35.16	-25.96	-26.9	Upgrade
Capital Expenditures	0	0	0	0.03	-0.09	Upgrade
Acquisitions	48.97	0	0	0	0	Upgrade
Investing Cash Flow	48.97	0	0	0.03	-0.09	Upgrade
Share Issuance / Repurchase	-0	0	98.22	48.92	15.25	Upgrade
Other Financing Activities	-0.03	-0.21	-0.18	25.08	-0.44	Upgrade
Financing Cash Flow	-0.03	-0.21	98.04	74	14.82	Upgrade
Exchange Rate Effect	-0.04	-0.16	-0.03	0.12	-0.22	Upgrade
Net Cash Flow	5.14	-49.42	62.85	48.18	-12.39	Upgrade
Free Cash Flow	-43.75	-49.04	-35.16	-25.93	-26.99	Upgrade
Free Cash Flow Margin	-	-	-2343.80%	-1728.80%	-	Upgrade
Free Cash Flow Per Share	-2.14	-4.33	-4.10	-4.37	-11.95	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).